Hematology
Conference Coverage
Video: Positive trends for outcomes in uric acid stroke trial gives optimism
News
FDA reviewers support approval of platelet inhibitor cangrelor for PCI indication
News
New tools for stroke prediction in atrial fibrillation
News
WOEST results guide antithrombotic therapy in PCI
News
FDA: Naproxen may pose lower CV risk
News
Inpatient safety efforts yield mixed results
Major finding: At least 81,000 adverse events were avoided in a single year in patients hospitalized for acute MI and heart failure.Data source: A...
News
FDA panel rejects rivaroxaban again for acute coronary syndrome
Conference Coverage
Statins reduce recurrent thromboembolism risk
Major finding: Patients on statin therapy had an adjusted 17% lower risk of recurrent venous thromboembolism in the year following their first...
Conference Coverage
In the real world, persistence on warfarin is low
Major finding: Less than one-half of patients with a first VTE started on warfarin within 10 days; of those who did, nearly 75% discontinued...
News
Low event rates with real-world use of rivaroxaban in NOAC
Major finding: The annual stroke rate with once-daily rivaroxaban was 1.4% and the major bleeding rate was 3.4% among 1,194 patients with atrial...